These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21617590)

  • 1. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers.
    Bertuzzo VR; Cescon M; Ravaioli M; Grazi GL; Ercolani G; Del Gaudio M; Cucchetti A; D'Errico-Grigioni A; Golfieri R; Pinna AD
    Transplantation; 2011 Jun; 91(11):1279-85. PubMed ID: 21617590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.
    Chun JM; Kwon HJ; Sohn J; Kim SG; Park JY; Bae HI; Yun YK; Hwang YJ
    J Surg Oncol; 2011 Feb; 103(2):148-51. PubMed ID: 21259248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
    Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
    De Carlis L; Giacomoni A; Pirotta V; Lauterio A; Slim AO; Sammartino C; Cardillo M; Forti D
    J Am Coll Surg; 2003 Jun; 196(6):887-97. PubMed ID: 12788425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate liver resection type for patients with the American joint committee on cancer classification T1 and T2 hepatocellular carcinoma.
    Hsieh CB; Chung KP; Chu CM; Yu JC; Hsieh HF; Chu HC; Yu CY; Chen TW
    Eur J Surg Oncol; 2011 Jun; 37(6):497-504. PubMed ID: 21450438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC.
    Matsuda M; Asakawa M; Amemiya H; Fujii H
    J Gastroenterol Hepatol; 2011 Apr; 26(4):731-8. PubMed ID: 21155886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation.
    Lohmann R; Bechstein WO; Langrehr JM; Knoop M; Lobeck H; Keck H; Lemmems HP; Blumhardt G; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1245-6. PubMed ID: 7533376
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
    Takada Y; Otsuka M; Todoroki T; Fukao K
    Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of preoperative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with hepatocellular carcinoma after living donor liver transplantation.
    Mori S; Choi Y; Park MS; Kim H; Hong G; Yi NJ; Lee KW; Suh KS
    Hepatogastroenterology; 2014; 61(136):2353-8. PubMed ID: 25699382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer.
    Mailey B; Artinyan A; Khalili J; Denitz J; Sanchez-Luege N; Sun CL; Bhatia S; Nissen N; Colquhoun SD; Kim J
    Arch Surg; 2011 Jan; 146(1):26-33. PubMed ID: 21242442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
    Chung IK; Park MJ; Kwon KT; Park YD; Chung YJ; Jeon SW; Lee MK; Seo HE; Lee YD; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
    Korean J Hepatol; 2005 Dec; 11(4):371-80. PubMed ID: 16380666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma].
    Yang LT; Cheng XD; Du YA; Wang XB; Zhang YL; Guo JM
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):612-6. PubMed ID: 20021950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
    Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
    Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
    Zhou LX; Yan LN
    Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M; Grazi GL; Principe A; Ravaioli M; Ercolani G; Cescon M; Varotti G; Gardini A; Cavallari A
    Hepatogastroenterology; 2004; 51(56):510-4. PubMed ID: 15086193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
    Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.